Bharat Biotech bets on vaccines to fight drug resistance, eyes post-Covid growth

Hyderabad-based Bharat Biotech is developing novel vaccines to combat antimicrobial resistance (AMR), a significant global health threat. The company aims to administer these vaccines pre-surgery to prevent hospital-acquired infections, addressing a growing need due to rising drug resistance.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/ulNcXrk
via IFTTT

Read More

Pharma companies struggle as input costs rise despite 0.6% price hike

Facing a modest 0.6% hike in medicine prices this year, pharmaceutical companies are grappling with the rising costs of raw materials fueled by global unrest. Starting April 1, essential medications such as pain relievers and antibiotics will adjust in price, prompting the industry to appeal to governments for financial relief to manage these escalating expenses.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/RjCi2NE
via IFTTT

Read More

Chirag Paswan says India working with global bodies on nutraceutical regulations

India is actively working with international regulatory bodies, including Codex Alimentarius Commission, to develop essential regulations for the rapidly expanding nutraceutical sector. The government recognizes the immense growth potential and is committed to addressing existing gaps. This initiative aims to foster a structured environment for the industry's advancement, ensuring nutritional security alongside food security for the nation.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/LTHxBrU
via IFTTT

Read More

Zydus’s weight-loss injection to reach India via Lupin partnership

Zydus Lifesciences and Lupin are joining forces. They will make a generic version of the popular weight-loss and diabetes drug semaglutide more accessible in India. This collaboration follows the upcoming expiry of Novo Nordisk's patent. Lupin will co-market Zydus's semaglutide injection under its own brand. This move aims to reach more patients across the country.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/duKU36L
via IFTTT

Read More

Zydus, Lupin sign pact to co-market weight-loss Semaglutide injection in India

Zydus Lifesciences and Lupin have joined forces to bring Semaglutide Injection to India. This medication helps manage type 2 diabetes and aids in chronic weight management. This collaboration aims to provide advanced therapies for metabolic disorders across the nation.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/KkhBqjl
via IFTTT

Read More

SC grills Sebi over lingering probe against Sandesara brothers despite Rs 5,100 cr settlement

In a surprising turn of events, the Supreme Court has scrutinised Sebi's ongoing actions against the directors of Sterling Biotech. This review arises following the directors’ hefty ₹5,100 crore settlement payment. Earlier, the court had invalidated all related cases. Sebi's investigation concerns the suspected routing of funds.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/cGoaAPK
via IFTTT

Read More

Sun Pharma’s Ilumya expansion bid gets USFDA nod for review

Sun Pharmaceutical has received a significant approval from the USFDA. The company's innovative drug, Ilumya, is now being considered for treating adults with active psoriatic arthritis. This marks a crucial step for Sun Pharma in expanding its medicine portfolio. The US regulator has accepted the application for review.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3ZMkVv2
via IFTTT

Read More